Utilizing Multiplex PCR and Next Generation Sequencing, VISTA Thalassemia-Seq screens for 4 types of Alpha-thal deletions, 3 types of Beta-thal deletions, over 508 thalassemia mutations, and more than 1000 Hb variants. With a quick 10-20 minute service time, results are delivered via email in approximately 21 business days. Suitable for women, men, and pregnant individuals before 14 weeks of gestation, no fasting required. Essential for those planning marriage, starting a family, or pregnancy, providing vital carrier status information for informed decisions.

Embarking on the journey of starting a family is a joyous occasion, but it's essential to ensure that potential genetic risks are identified and understood. VISTA Thalassemia-Seq offers comprehensive genetic screening, employing advanced Multiplex PCR and Next Generation Sequencing technologies to provide thorough insights into thalassemia-related genetic variations.

This screening encompasses a wide array of genetic markers, including screening for 4 types of Alpha-thal deletions, 3 types of Beta-thal deletions, over 508 thalassemia mutations, and more than 1000 Hb variants. This extensive panel ensures a comprehensive assessment of potential genetic risks associated with thalassemia and related hemoglobinopathies.

The testing process is designed to be quick and convenient, with a service time of just 10-20 minutes. Following sample collection—a simple 3 cc blood draw—results are typically delivered via email within approximately 21 business days. Moreover, there is no requirement for fasting prior to sample collection, minimizing inconvenience for individuals undergoing the screening process.

VISTA Thalassemia-Seq is suitable for individuals of all genders, including women, men, and pregnant individuals before 14 weeks of gestation. This inclusivity ensures that individuals at various stages of family planning can benefit from the valuable insights provided by this screening test.

This comprehensive genetic screening is particularly essential for individuals planning to marry, start a family, or embark on a pregnancy journey. By providing vital carrier status information, VISTA Thalassemia-Seq empowers individuals and couples to make informed decisions and preparations regarding family planning.

Priced competitively, VISTA Thalassemia-Seq represents an invaluable investment in the health and well-being of future generations. By proactively identifying potential genetic risks, individuals can take proactive steps to mitigate these risks and ensure the health and happiness of their families for generations to come.